Rocket Pharmaceuticals (RCKT) Non-cash Items (2014 - 2026)

Rocket Pharmaceuticals has disclosed Non-cash Items across 13 years of filings, most recently posting $1.5 million for Q1 2026.

• Non-cash Items for Q1 2026 came in at $1.5 million, down 95.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 million (down 95.18% YoY), and the FY2025 annual result was $706000.0, down 98.88% from the prior year.
• Non-cash Items came in at $1.5 million for Q1 2026 at Rocket Pharmaceuticals, up from $706000.0 in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $250.6 million in Q4 2023 to a low of $706000.0 in Q4 2025.
• The 5-year median for Non-cash Items is $88.5 million (2022), against an average of $89.6 million.
• Across the five-year window, Non-cash Items jumped 114.47% in 2024 and sank 98.88% in 2025, its largest moves.
• Rocket Pharmaceuticals' Non-cash Items stood at $118.8 million in 2022, then surged by 111.0% to $250.6 million in 2023, then sank by 74.74% to $63.3 million in 2024, then tumbled by 98.88% to $706000.0 in 2025, then soared by 109.35% to $1.5 million in 2026.
• The last three Non-cash Items figures came in at $1.5 million (Q1 2026), $706000.0 (Q4 2025), and $9.9 million (Q3 2025), per Business Quant data.